213 426

Cited 0 times in

Concurrent chemoradiotherapy in patients with nasopharyngeal cancer: prognostic significance of low expression of bax.

Kang, SY; Oh, YT; Han, JH; Choi, JH; Lim, HY; Kim, HI; Lee, HW; Jang, JH; Park, JS; Kim, HC; Kang, S; Chun, M; Kim, CH; Joo, HJ
Neoplasma, 53(5):450-456, 2006
Journal Title
A randomized trial has demonstrated that concurrent chemoradiotherapy (CRT) is superior to radiotherapy (RT) alone in locally advanced nasopharyngeal cancer (NPC). Our study comprise 35 patients with locally advanced NPC (stage I: 1, II: 12, III: 7, IV: 15) with 1 cycle of induction chemotherapy (5-fluorouracil 1,000 mg/m(2)/day and cisplatin 20 mg/m(2)/day, days 1- 4) followed by concurrent CRT starting on day 22. Concurrent CRT consisted of RT (70 Gy/35 fractions for 7 weeks) with cisplatin 20 mg/m(2)/day for 4 days on weeks 1, 4, 7 of RT. Complete response (CR) was achieved in 33 patients (94%). Four-year progression-free survival (PFS) and overall survival (OS) of all patients were 57% and 65%, respectively. In analysis of prognostic factors, low expression of bax was the most significant independent predictor of poor prognosis in both PFS (p=0.002) and OS (p=0.008). In conclusion, the outcome of patients treated with this combined therapeutical modality appears to be comparable with that of Intergroup 0099 trial with high CR rate. Low expression of bax was significantly associated with poor PFS and OS.
MeSH terms
AdultAntineoplastic Agents/therapeutic use*Cisplatin/therapeutic useCombined Modality TherapyFemaleFluorouracil/therapeutic useHumansMaleMiddle AgedNasopharyngeal Neoplasms/drug therapy*Nasopharyngeal Neoplasms/mortalityNasopharyngeal Neoplasms/radiotherapy*PrognosisSurvival AnalysisTumor Markers, Biological/analysisbcl-2-Associated X Protein/biosynthesis*
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Hematology-Oncology
Journal Papers > School of Medicine / Graduate School of Medicine > Radiation Oncology
Journal Papers > School of Medicine / Graduate School of Medicine > Pathology
Journal Papers > School of Medicine / Graduate School of Medicine > Otolaryngology
AJOU Authors
강, 석윤오, 영택한, 재호최, 진혁이, 현우장, 준호박, 준성김, 효철강, 승희전, 미선김, 철호주, 희재
Full Text Link
Files in This Item:
Full-Text Not Available.txtDownload
RIS (EndNote)
XLS (Excel)


해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.